1. Home
  2. OVID vs SPAI Comparison

OVID vs SPAI Comparison

Compare OVID & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • SPAI
  • Stock Information
  • Founded
  • OVID 2014
  • SPAI 2021
  • Country
  • OVID United States
  • SPAI United States
  • Employees
  • OVID N/A
  • SPAI N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • SPAI Industrial Specialties
  • Sector
  • OVID Health Care
  • SPAI Health Care
  • Exchange
  • OVID Nasdaq
  • SPAI Nasdaq
  • Market Cap
  • OVID 47.1M
  • SPAI 55.9M
  • IPO Year
  • OVID 2017
  • SPAI 2024
  • Fundamental
  • Price
  • OVID $0.45
  • SPAI $3.24
  • Analyst Decision
  • OVID Strong Buy
  • SPAI
  • Analyst Count
  • OVID 6
  • SPAI 0
  • Target Price
  • OVID $3.20
  • SPAI N/A
  • AVG Volume (30 Days)
  • OVID 312.2K
  • SPAI 164.6K
  • Earning Date
  • OVID 03-11-2025
  • SPAI 11-14-2024
  • Dividend Yield
  • OVID N/A
  • SPAI N/A
  • EPS Growth
  • OVID N/A
  • SPAI N/A
  • EPS
  • OVID N/A
  • SPAI N/A
  • Revenue
  • OVID $566,000.00
  • SPAI $1,559,057.00
  • Revenue This Year
  • OVID N/A
  • SPAI N/A
  • Revenue Next Year
  • OVID N/A
  • SPAI N/A
  • P/E Ratio
  • OVID N/A
  • SPAI N/A
  • Revenue Growth
  • OVID 44.50
  • SPAI 35.50
  • 52 Week Low
  • OVID $0.46
  • SPAI $1.56
  • 52 Week High
  • OVID $3.45
  • SPAI $6.50
  • Technical
  • Relative Strength Index (RSI)
  • OVID 30.65
  • SPAI N/A
  • Support Level
  • OVID $0.50
  • SPAI N/A
  • Resistance Level
  • OVID $0.58
  • SPAI N/A
  • Average True Range (ATR)
  • OVID 0.06
  • SPAI 0.00
  • MACD
  • OVID 0.00
  • SPAI 0.00
  • Stochastic Oscillator
  • OVID 13.30
  • SPAI 0.00

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About SPAI Safe Pro Group Inc. Common Stock

Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.

Share on Social Networks: